Search

Your search keyword '"Epelbaum, Stephane"' showing total 140 results

Search Constraints

Start Over You searched for: Author "Epelbaum, Stephane" Remove constraint Author: "Epelbaum, Stephane"
140 results on '"Epelbaum, Stephane"'

Search Results

1. Accuracy of MRI Classification Algorithms in a Tertiary Memory Center Clinical Routine Cohort

2. The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in 8 countries

3. Reproducible evaluation of diffusion MRI features for automatic classification of patients with Alzheimers disease

4. Neural correlates of episodic memory in the Memento cohort

5. COGEVIS: A New Scale to Evaluate Cognition in Patients with Visual Deficiency

9. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

11. Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers

12. Biomarker-guided clustering of Alzheimer's disease clinical syndromes

14. Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease

15. Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia

16. Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease

17. Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints

18. Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers: An INSIGHT-preAD study

20. Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1–42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40

21. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study

22. Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study

25. Prediction of Amyloidosis from Neuropsychological and MRI Data for Cost Effective Inclusion of Pre-symptomatic Subjects in Clinical Trials

30. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

32. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience

35. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

36. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020

39. Characteristics of subjective cognitive decline associated with amyloid positivity

40. Pilot Study of Repeated Blood-Brain Barrier Disruption in Patients with Mild Alzheimer's Disease with an Implantable Ultrasound Device

42. Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel

Catalog

Books, media, physical & digital resources